As COVID-19 continues to spread these days, our primary concern is the health and safety of our employees and patients globally. It is of a vital importance for us to set up the measures to protect them and to ensure further regular operations of AOP Orphan in all countries.
With that in mind, we have implemented following actions effective as from Monday, March 16 to April 30, 2020:
- General travel restrictions for all AOP Orphan employees.
- AOP Orphan Meetings are to be conducted digitally.
- All AOP Orphan employees are requested to work from home, except those who work in the departments that are of a core importance for company’s operations, e.g. Supply Chain Management, Drug Safety and Quality Assurance.
- Internal guidance on how our employees can protect themselves against coronavirus infection.
- Enacting plans to ensure further ongoing drug supply in all countries. We are working closely with local health authorities and governmental representatives as well as with our product manufacturers and distributors in affected countries to ensure that patients get access to the drugs without interruptions.
